03076nam 2200961z- 450 991059507400332120231214133358.0(CKB)5680000000080786(oapen)https://directory.doabooks.org/handle/20.500.12854/92097(EXLCZ)99568000000008078620202209d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierTreatments for Squamous Cell CancerBaselMDPI Books20221 electronic resource (168 p.)3-0365-4757-6 3-0365-4758-4 Squamous cell cancer (SCC) development and recent preclinical and clinical advances for the effective prevention and treatment of the disease are covered in this book. Experts in the field describe here the cellular and molecular events in SCC development, recurrence, and metastasis, and provide an updated snapshot on our understanding of the heterogeneity of SCC pathogenesis with novel opportunities in precision therapeutics to achieve better clinical outcomes.MedicinebicsscOncologybicsscoral cancertobaccoalcoholhuman papilloma virustargeted sequencingDNA copy numberTP53CDKN2AEGFRPIK3CAanal cancerradiation therapychemoradiationde-escalation of therapypaincathepsin Sprotease-activated receptor-2PAR2cancer painoral squamous cell carcinomadifferentiationterminal differentiationoral epitheliumepithelial integrityepithelial transformationgenetic alterationstherapy response biomarkerscutaneous squamous cell carcinomaimmunotherapyanti-PD1biomarkerspredictive medicinepersonalized medicinecancerimmune systemHNSCCfarnesyl transferasetipifarnibcombination regimenoropharynxneoplasmsquamous cell carcinomahuman papillomavirustherapeutic managementtreatment selectionCSCCtreatmentadvancesbiologyimmunocompromisedimmune checkpoint inhibitionMedicineOncologyDarido Charbeledt1332977Darido CharbelothBOOK9910595074003321Treatments for Squamous Cell Cancer3041180UNINA